I-44 Efficacy and relapse: peginterferon alpha-2a plus ribavirin combination therapy in Chinese patients with chronic hepatitis C in clinical practice

X.G.Dou; X.Y.Zhang

首页> 外文期刊>International journal of infectious diseases : >I-44 Efficacy and relapse: peginterferon alpha-2a plus ribavirin combination therapy in Chinese patients with chronic hepatitis C in clinical practice

【24h】

I-44 Efficacy and relapse: peginterferon alpha-2a plus ribavirin combination therapy in Chinese patients with chronic hepatitis C in clinical practice

机译：I-44疗效与复发：聚乙二醇干扰素α-2a联合利巴韦林在中国慢性丙型肝炎患者中的临床应用

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2008年第3期|共页
作者
X.G.Dou; X.Y.Zhang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of peginterferon alpha-2a and ribavirin combination therapy in treatment-naive Estonian patients with chronic Hepatitis C [J] . BrjalinV., SalupereR., TalloT., Central European journal of public health . 2012,第2期

机译：聚乙二醇干扰素α-2a和利巴韦林联合治疗在未接受治疗的爱沙尼亚慢性丙型肝炎患者中的疗效
2. Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety [J] . Steven K. Herrine MD, Robert S. Brown Jr. MD, David E. Bernstein MD, Digestive Diseases and Sciences . 2005,第4期

机译：接受标准干扰素α-2b加利巴韦林治疗的慢性丙型肝炎患者中或病毒突破后复发的聚乙二醇干扰素α-2a联合疗法：有效性和安全性的初步研究
3. Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. [J] . Witthoft T, Moller B, Wiedmann KH, Journal of viral hepatitis. . 2007,第11期

机译：在临床实践中，聚乙二醇干扰素α-2a和利巴韦林在慢性丙型肝炎中的安全性，耐受性和功效：德国公开安全性试验。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Safety tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial [O] . Th Witthöft, B Möller, K H Wiedmann, -1

机译：在临床实践中聚乙二醇干扰素α-2a和利巴韦林在慢性丙型肝炎中的安全性耐受性和有效性：德国公开安全性试验
7. I-44 Efficacy and relapse: peginterferon alpha-2a plus ribavirin combination therapy in Chinese patients with chronic hepatitis C in clinical practice [O] . Dou X.G., Zhang X.Y. 2008

机译：I-44疗效与复发：聚乙二醇干扰素α-2a联合利巴韦林在中国慢性丙型肝炎患者中的临床应用

I-44 Efficacy and relapse: peginterferon alpha-2a plus ribavirin combination therapy in Chinese patients with chronic hepatitis C in clinical practice

著录项

相似文献

相关主题

期刊订阅